Arcadia Biosciences (RKDA) Operating Expenses (2014 - 2025)

Arcadia Biosciences has reported Operating Expenses for 12 years, with the latest figure at $2.3 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses fell 34.88% year-over-year to $2.3 million; the trailing twelve-month figure through Dec 2025 stood at $7.4 million (down 15.38% YoY), and the FY2025 full-year result was $7.4 million, down 15.36% from the prior year.
• Operating Expenses for Q4 2025 stood at $2.3 million, down from $2.5 million in the prior quarter.
• The five-year high for Operating Expenses was $16.0 million in Q4 2021, with the low at -$2.0 million in Q4 2023.
• Historically, Operating Expenses has averaged $4.7 million across 5 years, with a median of $3.4 million in 2024.
• Annual changes were most pronounced in 2021 — Operating Expenses surged 4812.39% — and 2023, when it slumped 136.65%.
• Arcadia Biosciences' Operating Expenses stood at $16.0 million in 2021, then plunged by 66.18% to $5.4 million in 2022, then tumbled by 136.65% to -$2.0 million in 2023, then surged by 276.52% to $3.5 million in 2024, then plunged by 34.88% to $2.3 million in 2025.
• The last three Operating Expenses figures came in at $2.3 million (Q4 2025), $2.5 million (Q3 2025), and $2.0 million (Q2 2025), per Business Quant data.